Parravano, Mariacristina
Costanzo, Eliana
Borrelli, Enrico https://orcid.org/0000-0003-2815-5031
Sacconi, Riccardo https://orcid.org/0000-0003-2891-2012
Virgili, Gianni
Sadda, SriniVas R.
Scarinci, Fabio https://orcid.org/0000-0001-5444-4377
Varano, Monica
Bandello, Francesco
Querques, Giuseppe https://orcid.org/0000-0002-3292-9581
Article History
Received: 16 July 2019
Accepted: 3 January 2020
First Online: 21 January 2020
Competing interests
: The authors declare that there are potential conflicts of interest regarding the publication of this article. Mariacristina Parravano has the following disclosures: Allergan (S), Bayer (S); Novartis (S). Srinivas Sadda has the following disclosures: Heidelberg (C); Centervue (C); Optos (C); Carl Zeiss Meditc (S); Amgen (C); Allergan (C); Bayer (C); Novartis (C); Roche/Genentech (C); Oxurion (C). Monica Varano has the following disclosures: Allergan (S), Bayer (S); Novartis (S); Sifi (S). Francesco Bandello has the following disclosures: ALLERGAN (S), ALIMERA (S), BAYER (S), FARMILA-THEA (S), SCHERING PHARMA (S), SANOFI-AVENTIS (S), NOVAGALI (S), PHARMA (S), HOFFMANN-LA ROCHE (S), GENETECH (S), NOVARTIS (S). Giuseppe Querques has the following disclosures: ALLERGAN (S), ALIMERA (S), AMGEN (S), BAYER (S), KHB (S), NOVARTIS (S), ROCHE (S), SANDOZ (S), ZEISS (S). ALLERGAN (C), ALIMERA (C), BAUSCH AND LOMB (C), BAYER (C), HEIDELBERG (C), NOVARTIS (C), ZEISS (C). The other authors have nothing to disclose.